BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21953990)

  • 1. Pain in Parkinson's disease.
    Ha AD; Jankovic J
    Mov Disord; 2012 Apr; 27(4):485-91. PubMed ID: 21953990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain in Parkinson's disease.
    Ford B
    Mov Disord; 2010; 25 Suppl 1():S98-103. PubMed ID: 20187254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain in Parkinson's disease: analysis and literature review.
    Rana AQ; Kabir A; Jesudasan M; Siddiqui I; Khondker S
    Clin Neurol Neurosurg; 2013 Nov; 115(11):2313-7. PubMed ID: 24075714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-motor extranigral signs and symptoms in Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease.
    Nyholm D
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S13-7. PubMed ID: 17707679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain in Parkinson's disease.
    Ford B
    Clin Neurosci; 1998; 5(2):63-72. PubMed ID: 10785830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical approach to nonmotor sensory fluctuations in Parkinson's disease.
    Bayulkem K; Lopez G
    J Neurol Sci; 2011 Nov; 310(1-2):82-5. PubMed ID: 21872276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain in Parkinson disease: a review of the literature.
    Fil A; Cano-de-la-Cuerda R; Muñoz-Hellín E; Vela L; Ramiro-González M; Fernández-de-Las-Peñas C
    Parkinsonism Relat Disord; 2013 Mar; 19(3):285-94; discussion 285. PubMed ID: 23246139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiological basis of sensory disturbances in Parkinson's disease.
    Juri C; Rodriguez-Oroz M; Obeso JA
    J Neurol Sci; 2010 Feb; 289(1-2):60-5. PubMed ID: 19758602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to heat pain stimulation in idiopathic Parkinson's disease.
    Nandhagopal R; Troiano AR; Mak E; Schulzer M; Bushnell MC; Stoessl AJ
    Pain Med; 2010 Jun; 11(6):834-40. PubMed ID: 20624238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A; Ebersbach G
    Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of pain and fatigue in Parkinson's disease.
    Berardelli A; Conte A; Fabbrini G; Bologna M; Latorre A; Rocchi L; Suppa A
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S226-8. PubMed ID: 22166442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence.
    Bhidayasiri R; Truong DD
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S110-3. PubMed ID: 22166405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging analgesic drugs for Parkinson's disease.
    Perez-Lloret S; Rey MV; Dellapina E; Pellaprat J; Brefel-Courbon C; Rascol O
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):157-71. PubMed ID: 22530847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyskinesia in Parkinson's disease--major clinical features, aetiology, therapy].
    Ellrichmann G; Russ H; Müller T
    Fortschr Neurol Psychiatr; 2007 Jul; 75(7):387-96. PubMed ID: 17443441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensory symptoms in Parkinson's disease].
    Santos-García D; Aneiros-Díaz A; Macias-Arribi M; Llaneza-González MA; Abella-Corral J; Santos-Canelles H
    Rev Neurol; 2010 Feb; 50 Suppl 2():S65-74. PubMed ID: 20205145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.